Michael A. Panzara's Insider Trades & SAST Disclosures
Michael A. Panzara's most recent trade in Athira Pharma Inc was a trade of 20,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 24, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael A. Panzara.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Athira Pharma Inc | Michael A. Panzara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| Athira Pharma Inc | Michael A. Panzara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| Wave Life Sciences Ltd. | Michael A. Panzara | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 60,000 | 60,000 | - | - | Share Option (right to buy) | |
| Athira Pharma Inc | Michael A. Panzara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 2,311 | 2,311 | - | - | Stock Option (Right to Buy) | |
| Wave Life Sciences Ltd. | Michael A. Panzara | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 50,000 | 125,817 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd. | Michael A. Panzara | See Remarks | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 04 May 2022 | 16,714 | 109,103 (0%) | 0% | 1.7 | 28,748 | Ordinary Shares |
| Athira Pharma Inc | Michael A. Panzara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2022 | 27,742 | 27,742 | - | - | Stock Option (Right to Buy) | |
| Wave Life Sciences Ltd. | Michael A. Panzara | See Remarks | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 16 Feb 2022 | 10,603 | 75,817 (0%) | 0% | 2.3 | 24,493 | Ordinary Shares |
| Wave Life Sciences Ltd. | Michael A. Panzara | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 200,000 | 200,000 | - | - | Share Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges